These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29864763)

  • 1. Smoking in Schizophrenia: an Updated Review.
    Šagud M; Vuksan-Ćusa B; Jakšić N; Mihaljević-Peleš A; Rojnić Kuzman M; Pivac N
    Psychiatr Danub; 2018 Jun; 30(Suppl 4):216-223. PubMed ID: 29864763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking in schizophrenia: recent findings about an old problem.
    Sagud M; Mihaljevic Peles A; Pivac N
    Curr Opin Psychiatry; 2019 Sep; 32(5):402-408. PubMed ID: 31135490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective Cessation Strategies for Smokers with Schizophrenia.
    Evins AE; Cather C
    Int Rev Neurobiol; 2015; 124():133-47. PubMed ID: 26472528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving Smoking Cessation in Individuals with Schizophrenia: Special Considerations.
    Cather C; Pachas GN; Cieslak KM; Evins AE
    CNS Drugs; 2017 Jun; 31(6):471-481. PubMed ID: 28550660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.
    Parikh V; Kutlu MG; Gould TJ
    Schizophr Res; 2016 Mar; 171(1-3):1-15. PubMed ID: 26803692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute feasibility and safety of a smoking reduction strategy for smokers with schizophrenia.
    Dalack GW; Meador-Woodruff JH
    Nicotine Tob Res; 1999 Mar; 1(1):53-7. PubMed ID: 11072388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues.
    Ziedonis DM; George TP
    Schizophr Bull; 1997; 23(2):247-54. PubMed ID: 9165635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the role of pharmacotherapy in tobacco cessation in patients with schizophrenia?
    Els C
    J Psychiatry Neurosci; 2004 May; 29(3):240. PubMed ID: 15173898
    [No Abstract]   [Full Text] [Related]  

  • 10. Demographics, clinical characteristics and cognitive symptoms of heavy smokers and non-heavy smokers in Chinese male patients with chronic schizophrenia.
    Wei S; Wang D; Zhou H; Xia L; Tian Y; Dai Q; Zhu R; Wang W; Chen D; Xiu M; Wang L; Zhang X
    Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1325-1333. PubMed ID: 35474549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.
    Brody AL; Zorick T; Hubert R; Hellemann GS; Balali S; Kawasaki SS; Garcia LY; Enoki R; Abraham P; Young P; McCreary C
    Nicotine Tob Res; 2017 Jan; 19(1):68-76. PubMed ID: 27613888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group treatment for smoking cessation among persons with schizophrenia.
    Addington J
    Psychiatr Serv; 1998 Jul; 49(7):925-8. PubMed ID: 9661227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices.
    Evins AE; Cather C; Laffer A
    Harv Rev Psychiatry; 2015; 23(2):90-8. PubMed ID: 25747922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reasons for smoking cessation attempts among Japanese male smokers vary by nicotine dependence level: a cross-sectional study after the 2010 tobacco tax increase.
    Tanihara S; Momose Y
    BMJ Open; 2015 Mar; 5(3):e006658. PubMed ID: 25795690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-morbid tobacco use disorder and depression: A re-evaluation of smoking cessation therapy in depressed smokers.
    Morozova M; Rabin RA; George TP
    Am J Addict; 2015 Dec; 24(8):687-94. PubMed ID: 26354720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking cessation in schizophrenia. General practice guidelines.
    Strasser K; Moeller-Saxone K; Meadows G; Hocking B; Stanton J; Kee P
    Aust Fam Physician; 2002 Jan; 31(1):21-4. PubMed ID: 11840883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 6-Week Use of Reduced-Nicotine Content Cigarettes in Smokers With and Without Elevated Depressive Symptoms.
    Tidey JW; Pacek LR; Koopmeiners JS; Vandrey R; Nardone N; Drobes DJ; Benowitz NL; Dermody SS; Lemieux A; Denlinger RL; Cassidy R; al'Absi M; Hatsukami DK; Donny EC
    Nicotine Tob Res; 2017 Jan; 19(1):59-67. PubMed ID: 27613885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine Dependence and Willingness to Quit Smoking in Vascular Surgery Patients.
    Smeds MR; Privratsky A; Thrush CR; Barone CP; Escobar GA; Ali AT; Moursi MM
    Ann Vasc Surg; 2017 Nov; 45():144-153. PubMed ID: 28647633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol.
    Allen SI; Foulds J; Pachas GN; Veldheer S; Cather C; Azzouz N; Hrabovsky S; Hameed A; Yingst J; Hammett E; Modesto J; Krebs NM; Zhu J; Liao J; Muscat JE; Richie J; Evins AE
    BMC Public Health; 2017 Jan; 17(1):100. PubMed ID: 28103841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
    Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
    Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.